US 8217158
Immunotoxin fusion proteins and means for expression thereof
granted A61KA61K47/6829A61K47/6849
Quick answer
US patent 8217158 (Immunotoxin fusion proteins and means for expression thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 4
- CPC classes
- A61K, A61K47/6829, A61K47/6849